Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
proton pump inhibitor |
| gptkbp:approvedBy |
1994
|
| gptkbp:ATCCode |
gptkb:A02BC02
|
| gptkbp:bioavailability |
77%
|
| gptkbp:CASNumber |
138786-67-1
|
| gptkbp:chemicalFormula |
C16H14F2N3NaO4S
|
| gptkbp:developedBy |
gptkb:Byk_Gulden
|
| gptkbp:eliminationHalfLife |
about 1 hour
|
| gptkbp:excretion |
urine
feces |
| https://www.w3.org/2000/01/rdf-schema#label |
pantoprazole sodium
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits H+/K+ ATPase in gastric parietal cells
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
98%
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain headache |
| gptkbp:synonym |
gptkb:Pantoloc
gptkb:Somac gptkb:Protonix |
| gptkbp:usedFor |
treatment of peptic ulcer disease
treatment of Zollinger-Ellison syndrome treatment of gastroesophageal reflux disease |
| gptkbp:bfsParent |
gptkb:pantoprazole
|
| gptkbp:bfsLayer |
6
|